MeSH tree: D23.050.301
Pancreatic cancer is among the deadliest forms of cancer, with most patients diagnosed after the disease has already spread throughout the body. The five-year survival rate for metastatic cases hovers around 2–3%, and median ...
Nov 25, 2025
0
190
HLA compatibility is considered the key criterion for selecting donors for allo-HSCT. DKMS study data presented at the DGHO Annual Meeting 2025 in Cologne indicate the biological age of donors has a greater influence on transplant ...
Nov 19, 2025
0
16
In a surprising discovery, a "sticky molecule" that occurs naturally in our blood vessels could be both a culprit behind blood clots and organ failure during COVID and long COVID and the key to new treatments to counter COVID-related ...
Nov 17, 2025
0
19
In Alzheimer's disease—the leading cause of dementia—microglia, the brain's immune defenders, can act as both protectors and aggressors, shaping how the disease progresses.
Nov 5, 2025
0
16
Zenocutuzumab (Bizengri), a bispecific antibody that targets human epidermal growth factor receptor 2 (HER2) and HER3, led to responses in more than a third of patients with neuregulin 1 (NRG1)-positive cholangiocarcinoma, ...
Oct 22, 2025
0
15
Triple-negative breast cancer is one of the most aggressive cancers. The name tells the story: It lacks the three main targets that make other types of breast cancers more treatable with powerful therapies.
Oct 22, 2025
0
44
An alliance of scientists at the Broad Institute and Bayer Pharmaceuticals have developed a drug candidate, sevabertinib, that could be a new treatment for a group of lung cancer patients who have few options today.
Oct 17, 2025
0
30
A recent Finnish study investigated the effects of A2 milk, marketed as a gut-friendly alternative, and protein-hydrolyzed lactose-free milk on gastrointestinal symptoms and inflammation levels. The study found that protein-hydrolyzed ...
Sep 29, 2025
0
37
A study conducted by the Molecular Oncology Research Center (CPOM) at Hospital de Amor in Barretos (formerly Barretos Cancer Hospital) in the state of São Paulo, Brazil, has identified possible biomarkers that could guide ...
Sep 19, 2025
0
24
A new study, led by researchers at Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine, captured details of glioblastoma that had never before been seen and revealed a surprise ...
Sep 18, 2025
0
13
